Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk. Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […]
The kindness section highlights people helping people: strangers stepping in during emergencies, communities rallying around neighbors, small acts that ripple outward. These are not performative charity stories; they are moments where someone chose to act when they did not have to.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
French energy supermajor TotalEnergies recently inaugurated the largest hybrid renewable energy project in Africa that w…
A sisters-owned pizza institution in Minnesota which recently closed after fire damage has received a big slice of help …
It was June 23rd when a furry brown arrow shot past a motion-activated camera along the Bronx River and sent conservatio…
It’s estimated that over 110 million Chinese live and work abroad, which for the family members they leave behind can be…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →